Next report date
Report period
H2 2024
EPS estimate
0.25EUR
Revenue estimate
52.12 MEUR
0.5EUR
37.03 MEUR
76.26 MEUR
50.25 M
About PRO MEDICUS LIMITED
Sector
Industry
CEO
Sam Aaron Hupert
Website
Headquarters
Richmond
Founded
1983
ISIN
AU000000PME8
FIGI
BBG00GCTJN33
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PRO MEDICUS LTD. stocks are traded under the ticker PMC.
PRO MEDICUS LTD. is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
PMC earnings for the last quarter are 0.20 EUR per share, whereas the estimation was 0.19 EUR resulting in a 4.23% surprise. The estimated earnings for the next quarter are 0.22 EUR per share. See more details about PRO MEDICUS LTD. earnings.
PRO MEDICUS LTD. revenue for the last quarter amounts to 41.52 M EUR despite the estimated figure of 40.55 M EUR. In the next quarter revenue is expected to reach 47.47 M EUR.
Yes, you can track PRO MEDICUS LTD. financials in yearly and quarterly reports right on TradingView.
PMC net income for the last quarter is 22.36 M EUR, while the quarter before that showed 20.43 M EUR of net income which accounts for 9.44% change. Track more PRO MEDICUS LTD. financial stats to get the full picture.
PRO MEDICUS LTD. dividend yield was 0.46% in 2023, and payout ratio reached 51.64%. The year before the numbers were 0.52% and 51.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, PMC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRO MEDICUS LTD. stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on PRO MEDICUS LTD. future price: according to them, PMC price has a max estimate of 92.08 EUR and a min estimate of 34.89 EUR. Read a more detailed PRO MEDICUS LTD. forecast: see what analysts think of PRO MEDICUS LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PRO MEDICUS LTD. EBITDA is 64.17 M EUR, and current EBITDA margin is 73.50%. See more stats in PRO MEDICUS LTD. financial statements.